OKYO Pharma Chairman Acquires Company Shares

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, has announced that its Chairman and Founder has acquired additional shares in the company. This move by a key insider signals a potential belief in the company's future prospects and ongoing development pipeline. While specific details of the acquisition were not disclosed, such insider buying can often be interpreted as a positive indicator by the market, suggesting confidence from leadership in the company's valuation and growth trajectory.